Lenvima 4 MG Daily Dose and Bleeding
Result of checking the interaction of drug Lenvima 4 MG Daily Dose and disease Bleeding for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Hemorrhagic events, including fatal hemorrhagic events have been reported with the use of lenvatinib. It is recommended to withhold treatment and to either resume at a reduced dose or discontinue treatment depending on the severity and persistence of hemorrhage. Discontinue therapy in patients who experience severe or fatal hemorrhagic events. Prior to initiating treatment, consider the risk of severe or fatal hemorrhage associated with tumor invasion/infiltration of major blood vessels (e.g. carotid artery).
Generic Name: lenvatinib
Brand Name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvima